首页> 外文期刊>Biochemistry and Biophysics Reports >PCR-RFLP and FTIR-based detection of high-risk human papilloma virus for cervical cancer screening and prevention
【24h】

PCR-RFLP and FTIR-based detection of high-risk human papilloma virus for cervical cancer screening and prevention

机译:PCR-RFLP和基于FTIR的高危人乳头瘤病毒的宫颈癌筛查和预防

获取原文
           

摘要

BackgroundApproximately 70% of cervical carcinoma cases show the presence of high-risk Human Papilloma Virus (HPV), especially HPV-16 and HPV-18, and can be used to stratify high risk patients from low risk and healthy. Currently, molecular biology techniques such as polymerase chain reaction (PCR) are used to identify the presence of virus in patient samples. While the methodology is highly sensitive, it is labor intensive and time-consuming. Alternative techniques, such as vibrational spectroscopy, has been suggested as a possible rapid alternative. Therefore, in this study, we evaluate the efficiency of cervical fluid Fourier Transform Infrared spectroscopy (FTIR) in patient risk stratification informed by PCR.MethodsCervical fluid samples (n?=?91) were obtained from patients who have undergone routine Papanicolaou (Pap) test. Viral genome was identified and classified as high/low-risk by PCR-Restriction Fragment Length Polymorphism (PCR-RFLP). FTIR spectra were acquired from samples identified by PCR-RFLP as No-HPV (n?=?10), high-risk HPV (n?=?7), and low-risk HPV (n?=?7).ResultsOf the 91 samples, was detected the viral genome by PCR in 36 samples. Of these 36 samples, nine samples were identified to contain high-risk HPV (HR-HPV) and nine samples were found to have low-risk HPV (LR-HPV). The FTIR spectra acquired from No-HPV, LR-HPV, and HR-HPV showed differences in 1069, 1437, 1555, 1647, 2840, 2919, and 3287?cm-1bands. Principal Component Analysis (PCA) showed distinct clusters for No-HPV and HR-HPV and No-HPV and LR-HPV, but there was significant overlap in the clusters of HR-HPV and LR-HPV. PCA-Linear Discriminant Analysis (PC-LDA) after Leave One Out Cross Validation (LOOCV) classified No-HPV from HR-HPV and No-HPV from LR-HPV with 100% efficiency in the 1400-1800?cm-1spectral range. LOOCV classifications for LR-HPV and HR-HPV from each other were 71 and 75%, respectively, in the 2800-3400?cm-1spectral range.ConclusionsThe results highlight the high sensitivity of PCR-RFLP in HPV identification and show that FTIR can classify samples identified as healthy, low, and high-risk samples by PCR-RFLP.General significanceWe show the possibility of using FTIR for initial cervical cancer risk stratification followed by detailed PCR-RFLP investigations for suspect cases.
机译:背景,70%的宫颈癌病例显示出高风险的人乳头瘤病毒(HPV),特别是HPV-16和HPV-18,并且可用于分层高危患者从低风险和健康。目前,诸如聚合酶链反应(PCR)之类的分子生物学技术用于鉴定病毒在患者样品中的存在。虽然方法论高度敏感,但它是劳动密集且耗时的。已经提出了诸如振动光谱的替代技术作为可能的快速替代方案。因此,在本研究中,我们评估PCR的患者风险分层中宫颈流体傅里叶变换红外光谱(FTIR)的效率。从经过常规Papanicolaou(PAP)的患者中获得了患者的患者风险分层。(N?= 91)测试。通过PCR限制性片段长度多态性(PCR-RFLP)鉴定病毒基因组并归类为高/低风险。从PCR-RFLP鉴定的样品中获得FTIR光谱,作为NO-HPV(n?= 10),高风险HPV(n?=?7),低风险HPV(n?=?7)。resultsof通过PCR在36个样品中检测到病毒基因组的样品。在这36个样品中,鉴定了含有高风险HPV(HR-HPV)的九个样品,发现九个样品具有低风险的HPV(LR-HPV)。从No-HPV,LR-HPV和HR-HPV获得的FTIR光谱在1069,1437,1555,1647,2840,2919和3287?CM-1BAND中显示出差异。主成分分析(PCA)显示NO-HPV和HR-HPV和NO-HPV和LR-HPV的不同簇,但在HR-HPV和LR-HPV簇中存在显着重叠。 PCA-Linear判别分析(PC-LDA)在留出1次交叉验证(LOOCV)后,从HR-HPV和No-HPV从LR-HPV提供100%的1400-1800?CM-1光谱范围。 LR-HPV和HR-HPV的LOOCV分类分别为71和75%,分别在2800-3400?CM-1分光范围内。结论效果突出了HPV识别中PCR-RFLP的高灵敏度,并显示了FTIR可以通过PCR-RFLP,将鉴定为健康,低和高风险样品的样本进行分类。一般的意义威士力展示了使用FTIR进行初始宫颈癌风险分层的可能性,然后进行了可疑病例的详细PCR-RFLP调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号